Baylor College of Medicine

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Baylor College of Medicine sits in the top decile of US sponsors by registered trial count (#56 of 15,742 sponsors by registered trial count).

616 total trials 93 currently recruiting 376 completed early-phase tilt top decile by trial count

Baylor College of Medicine: 616 sponsored US clinical trials, 93 recruiting.

Baylor College of Medicine sponsors 616 registered US clinical trials on ClinicalTrials.gov, 93 of them currently recruiting, and 376 completed. 59 of these trials are in Phase 3-4 (later-stage) and 232 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Non-Hodgkin Lymphoma, with 7 trials.

Top-decile sponsor footprint

Baylor College of Medicine ranks in the top decile of sponsors by registered trial count (#56 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

F 47/100

376 of 452 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (83.2%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

616 total, page 9 of 13

COMPLETED Phase 1

A Pilot Study of Cabergoline for the Treatment of Cocaine Dependence

NCT01651364

COMPLETED

Sleep Abnormalities in Rare Genetic Disorders: AS, RTT, and PW

NCT02670694

TERMINATED

EUS Evaluation of Perianal and Peri-rectal Fistulizing Crohn's Disease With CERTOLIZUMAB Treatment

NCT01582568

COMPLETED

MER Versus MRI Guidance DBS in Parkinson's Disease

NCT01883973

COMPLETED Phase 4

A Comparison of UGBRS Block and Local Infiltration

NCT02352519

COMPLETED NA

A Comparison of Cognitive Function After Carotid Endarterectomy and Stenting

NCT02220595

TERMINATED Phase 4

A Comparison of UGSB and GA to IV Narcotics and GA for Post-Op Pain in Children With Supracondylar Fractures.

NCT02056288

COMPLETED NA

Study of Dopamine Versus Vasopressin for Treatment of Low Blood Pressure in Low Birth Weight Infants

NCT01318278

COMPLETED NA

Calcium Absorption in Patients With Rothmund-Thomson Syndrome

NCT01304407

COMPLETED Phase 1

DOX as a Potential Treatment for Methamphetamine Dependence

NCT02785393

COMPLETED NA

Effectiveness of Electronic Health Record-Based Interventions for Improving Follow-Up in Primary Care

NCT01346839

COMPLETED NA

Delivered Dietary Intervention for Children With Irritable Bowel Syndrome

NCT01339117

COMPLETED

Healthy Eating and Lifestyle for Total Health

NCT02725970

COMPLETED Phase 1

Administration of Rapidly Generated Multivirus-specific Cytotoxic T-Lymphocytes (VIRAGE)

NCT01070797

COMPLETED Phase 1

Varenicline as a Treatment for Methamphetamine Dependence

NCT01571167

COMPLETED Phase 1

Study to Evaluate Safety and Toxicity of Polyphenon E (EGCG) in HIV-1-Infected Individuals

NCT01433289

COMPLETED NA

Umbilical Cord Blood Transplant for Children With Myeloid Hematological Malignancies

NCT01247701

TERMINATED Phase 1

Administration of CMV-Specific Cytotoxic T Cells in Patients With Glioblastoma Multiforme

NCT01205334

COMPLETED Phase 1

CMV-specific Cytotoxic T Lymphocytes Expressing CAR Targeting HER2 in Patients With GBM

NCT01109095

COMPLETED

39946-I Laser and Bevacizumab Treatment for Retinopathy of Prematurity

NCT01993043

COMPLETED Phase 4

The Management of Glucocorticoid-Induced Hyperglycemia in Hospitalized Patients

NCT01810952

COMPLETED NA

Pain After Laparoscopic Cholecystectomy With Bilateral Tranversus Abdominis Plane (TAP) Block Versus Local Anesthetic Infiltration

NCT01204892

COMPLETED Phase 1

Role of HIV on Glutathione Synthesis and Oxidative Stress

NCT01355198

COMPLETED Phase 1

Modafinil - Escitalopram Study for Cocaine Dependence

NCT01601730

COMPLETED Phase 2

Multisite Controlled Trial of Cocaine Vaccine

NCT00969878

COMPLETED

Quality Improvement Project - Evaluation of Current Standard of Care for Feeding Practices in the NICU

NCT01204983

COMPLETED

Abdominal Symptom Phenotype Study in Children

NCT01204515

COMPLETED NA

Intranasal Oxytocin and Maternal Neglect

NCT02737436

COMPLETED NA

Test of an Intervention to Improve HIV Care

NCT01103856

COMPLETED

Energy Expenditure and Physical Activity in Preschoolers

NCT02075359

COMPLETED Phase 4

Effect of Exenatide on Liver and Heart Fat and Inflammation

NCT01951651

COMPLETED Phase 1

NAC as a Potential Treatment for Methamphetamine Dependence

NCT01063205

COMPLETED Phase 2

Pharmacogenetics of Doxazosin for Cocaine Dependence

NCT01145183

COMPLETED Phase 4

Does Pioglitazone Increase the Production of 15-EPI-Lipoxin A4?

NCT01040819

TERMINATED Phase 2

Mission Connect Mild Traumatic Brain Injury (TBI) Integrated Clinical Protocol

NCT01013870

COMPLETED Phase 1

The Effects of Doxazosin on the Cardiovascular and Subjective Effects of Cocaine

NCT01062945

COMPLETED NA

Active Video Games and Sustainable Physical Activity

NCT01024153

COMPLETED Phase 2

Carboplatin and Docetaxel Followed by Epstein-Barr Virus Cytotoxic T Lymphocytes

NCT00953420

COMPLETED NA

Pilot Study Using a Dietary Intervention for Children With Irritable Bowel Syndrome

NCT01018498

COMPLETED Phase 2

Squire's Quest! II: Implementation Intentions and Children's Fruit, Juice, and Vegetable (FJV) Consumption

NCT01004094

COMPLETED Phase 2

Valproic Acid, Radiation, and Bevacizumab in Children With High Grade Gliomas or Diffuse Intrinsic Pontine Glioma

NCT00879437

COMPLETED Phase 1

Safety Study of Probiotics in Adults With Irritable Bowel Syndrome

NCT00971711

COMPLETED NA

Pain After Laparoscopic Cholecystectomy

NCT00983918

COMPLETED NA

Family Eats:Cancer Prevention for Families

NCT00983840

COMPLETED NA

An Interactive Web-Based Program to Improve Food and Activity Choices of Teens

NCT00983567

COMPLETED Phase 1

The Efficacy of Doxazosin for Cocaine Users

NCT00880997

COMPLETED NA

Umbilical Cord Blood Transplant for Congenital Pediatric Disorders

NCT00950846

COMPLETED

Genetic Influences Between Cognitive Function and BMI

NCT03116334

COMPLETED NA

Healthy Kids-Houston: A Community Childhood Obesity Intervention Program

NCT00994084

COMPLETED Early Phase 1

Nitric Oxide Production in MELAS Syndrome

NCT01339494

← Previous Page 9 of 13 Next →

Phase Distribution

PhaseTrial count
Phase 1 173
Phase 2 59
Phase 3 13
Phase 4 46

What is open in the Baylor College of Medicine pipeline

93 recruiting of 616 indexed (15% open); 376 completed (61%).

Phase mix: 59 late (III/IV) vs 232 early (I/II) (early-phase heavy).

Top condition: Non-Hodgkin Lymphoma (7 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Baylor College of Medicine: open-pipeline peers nationwide

Peers matched on 616 registered trials and 15% open enrollment, not the therapeutic-area sidebar.

Baylor College of Medicine sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 05001,0001,5002,000 0%5%10%15%20% Total trials Recruiting share Baylor College of MedicineUniversity of Southern CaliforniaUS Department of Veterans AffairsUniversity of RochesterJanssen Research & DevelopmentStanford UniversityBaylor UniversityCornell University59th Medical Wing
Baylor College of Medicine sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Baylor College of Medicine sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 616 trials (± recruiting share)

Sponsors near 15% open enrollment (± trial volume)

What to do with this Baylor College of Medicine page

616 registered trials is a research-attention snapshot, not an endorsement of Baylor College of Medicine or any single study.

  • 93 of Baylor College of Medicine's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Non-Hodgkin Lymphoma is the condition Baylor College of Medicine studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Non-Hodgkin Lymphoma trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Baylor College of Medicine pipeline card: 616 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.